A S RECENTLY AS 1929 the first correct preoperative diagnosis of a pheochromocytoma was made and followed by resection. 1 Between 1945 and 1954, the pharmacological tests 2 " 5 and the determination of urine catecholamines 0 ' 7 were described and found to improve the accuracy of preoperative diagnosis of chromaffin tumors significantly. 8 Despite these advances, the majority of such tumors continued to be discovered at autopsy. 9 " 11 Even the best of the pharmacological tests, those using histamine and phentolamine, were subject to occasional misleading results and caused discomfort to the patient. 8 
' 12~15
Catecholamine determinations offered significantly greater reliability but they required complex equipment and highly trained laboratory personnel. 6 " 8 ' 16 ' 17 Until recently, none of these tests fulfilled the requirements of general availability, absence of untoward side effects, accuracy, and the economy necessary for a screening procedure.
While systematically studying the excretion of phenolic acids in the urine of human subjects, Armstrong and his co-workers 18 were impressed by the occurrence of O-methylated derivatives of these acids. Amine oxidation of the side chain of epinephrine and norepinephrine, with the formation of a mandelie acid derivative, had been suspected previously (fig. I). 1 9 ' 2 0 Further modification of this structure by O-methylation of the hydroxyl group in the meta position to the side chain would have been expected to yield 3-methoxy,-4-hydroxymandelic acid (VMA, for vanillylmandelie acid). In 1957, Armstrong and his co-workers succeeded in demonstrating that normal human subjects excreted this substance and that patients with pheochromocytomas excreted abnormally large quantities of VMA in their urines. 21 ' 22 Shortly thereafter Axelrod described the transferase responsible for catechol-O-methylation and suggested that O-methylation preceded amine oxidation of epinephrine and norepinephrine, with the consequent formation of their respective 3-O-methyl congeners, metanephrine and normetanephrine (fig. I). 23 " 25 Methods for the determination of metanephrine, normetanephrine, and their respective conjugates were too unwieldly to be clinically useful for the detection of pheochromocytomas. 26 ' 27 Moreover, recent studies demonstrated that tritium-labeled VMA (H 3 -VMA) far exceeded tritium-labeled normetanephrine (H 3 -NM) excretion after intravenous administration of tritium-labeled norepinephrine (cZZ-beta-H 3 -NE). 28 In 1958, a comparative study of epinephrine, norepinephrine, and VMA excretion in normal human subjects and in those with essential hypertension and pheochromocytomas was initiated. 29 ' 30 Attempts were made to (a) determine the value of the urine VMA assay for the diagnosis of pheochromocytoma 29 and (b) develop a new and simple technique suitable for the detection of these tumors by routine screening of large numbers of hypertensive subjects. 30 ' 31 This report is an evaluation of the degree of success attained, as well as a review of the r esults of such studies performed upon almost 300 hypertensive subjects.
Methods
Scmiquantitative determinations of urinary VMA can be accomplished most simply by bidirectional paper cliromatography of ethyl acetate extracts of acidified urine aliquots. 29 It yields a reproducible accurcy of ± 10 per cent and has Under ordinary circumstances, any random urine specimen will suffice for a VMA determination by this technique. No immediate acidification or refrigeration of the urine specimen is necessary, and urine VMA is stable at 10 C. for months or years.
Since the chromatographic technique is too cumbersome for routine screening of hypertensive patients for the detection of chromaffin tumors, it is preferable to use a simple colorinietric procedure, which was developed for this purpose in 195!). 30 A volume of urine equivalent to 0.5 mg. ereatinine is acidified and extracted with ethyl acetate. The extract containing the phenolic acids is reduced to dryness, taken up in dilute K 2 C0 3 , and coupled with diazotized p-nitroaniline. The violet AZO-VMA* thus formed is extracted into Jf-amyl alcohol and the densities at 450 and 550 m^ are determined with a Beckman DU spectrophotometer.
*At the suggestion of Dr. A. Smith, the formula previously depicted for AZO-VMA 30 was found to be in error. Studies with beta-H*-VMA reveal that the side chain of VMA is lost and that the coupling likely takes place at this point.
The ratio (R) of D 430 /D 350 reflects the VMA concentration in a semiquantitative manner when the patient follows a diet free of coffee, fruit, and vanilla for 48 hours prior to the collection of the urine. Ingestion of coffee gives rise to a urinary product tentatively identified as 3methoxy, 4-hydroxyphenylhydracrylie acid, which yields a violet color with diazotized p-nitroaniline. 29 ' 32 ' 33 This substance, as well as those urinary phenolic acids derived from ingestion of fruit, cake, candy, or ice cream, can give rise to an R value (<1.30) suggesting the presence of an abnormally large quantity of VMA (> 4 to 5 /xg./mg. creatinine). Such false positive results can be accurately evaluated by paper ehromatography, but this entails a time-consuming procedure for every patient who fails to follow the prescribed diet.
A recent modification of this colorinietric test 31 discards or destroys enough of the exogenously derived phenolic acids to permit semiquantitative assay of VMA in the urine of a patient who has not observed any dietary restrictions. A volume of urine equivalent to 1.0 mg. creatinine is acidified with hydrochloric acid to a pIT of 2 and placed in boiling water for 10 minutes. 29 The pH is then adjusted to exactly 4.0 by means of a 0.5 N acetate buffer, and the sample is extracted three times with ethyl acetate. The latter is discarded, the sample is acidified with hydrochloric G1TL0W, MEXDLOWITZ.. KRUK, KHASSIS *The majority of epinephrine and norepinephrine determinations were performed in the laboratory of Dr. Gerald Cohen.
Results
The paper chromatographic technique reveals that normal subjects as well as those with primary hypertension excrete between 0.5 and 4.0 jxg. VMA/mg. creatinine (about 2 to 3 ing VMA/day). Epinephrine and norepinephrine excretion average 0.002 and 0.013 /xg./mg. creatinine respectively in these groups. Their mean VMA excretion exceeds the mean catecholainine excretion by ]00-fold. Those subjects who observe the dietary restrictions are found by the simplified screening test to have E values in the range of 1 4 was employed (hereafter referred to as the double extraction technique). Among approximately 300 urine samples, the screening test never failed to demonstrate an R value less than 1.30 when more than 4 to 5 /*g. VMA/mg. creatinine was present. In this same group, the double extraction method revealed only a single instance of an R value less than 1.30 associated with a normal VMA excretion. The range of R values by either of the screening methods was found to be the same for normal subjects as for those with primary hypertension. Table 1 presents the paper chromatographic VMA, catecholamine, and VMA screeningtest results of 41 patients prior to the removal of the pheochromocytoma. The mean VMA excretion for these patients is 16 .5 jxg./ mg. ereatinine (range, 5 to 40 /xg. VMA/mg. creatinine). The R values for either the single or double extraction screening test are less than 1.16 in all but one case. Because of the relatively low VMA excretion of subject 41, five preoperative urine samples were studied. One of these revealed an R value greater than 1.30, the only known instance in this series of a normal VMA excretion in the presence of a pheochromocytoma. On the other hand, six subjects (nos. 14, 17, 18, 25, 27 , and 42) had normal or near-normal catecholamine excretion in the face of elevated VMA excretion.
Although diet influences the pattern of phenolic acid excretion apparent upon the paper chromatograms, it fails to affect the VMA spot. The VMA in a single subject's random urine samples collected at different times of the day does not vary beyond the normal range. A random urine specimen collected from a patient on an uncontrolled diet may, however, necessitate the double extraction rather than the single extraction screening test. Neither the paper chromatographic nor the double extraction screening test is seriously disturbed by previous administration of tetracycline, novobiocin, aeetylsalicylic acid, digoxin, meperidine, chlorothiazide, phenylephrine, naphazoline, ephedrine, isopropyl-arterenol, phenobarbital, seeobarbital, atropine, or by the ingestion of coffee, tea, fruit, or vanilla-containing substances. In fact, ingestion of as much as 8 rag. epinephrine fails to raise the urine VMA from the normal to the pheochromocytoma range.
Seriously ill patients with severe pulmonary insufficiency, metastatic tumors, or shock may have an abnormally elevated VMA excretion which overlaps with that quartile of patients with pheochromoeytomas who excrete the least VMA. Patients with metastatic carcinoid also demonstrate minimally elevated VMA excretion (about 5 ^g. VMA/mg. creatinine). Their high 5-hydroxyindoleacetic acid (5-HIAA) excretion is readily apparent on the paper chromatograms, making this test diagnostically useful for detecting the carcinoid syndrome. The high 5-HIAA excretion may produce a false positive result with the single extraction VMA screening test, but it fails to affect the double extraction test.
None of these patients offered serious diagnostic difficulties insofar as chromaffin tumors were concerned. On the other hand, one young subject suffering from accelerated hypertension with severe hypertensive encephalopathy had elevated VMA excretion after the intravenous administration of phentolamine. Abdominal exploration failed to reveal a pheochromocytoma, and permission for a postmortem examination was not obtained when he died a few months later. This represents the only subject who was suspected of having a pheochromocytoma, whose VMA excretion was elevated by the chromatographic technique, but who failed to reveal that tumor upon exploration.
Drugs that interfere with the formation or metabolism of the catecholamines, such as monamine oxidase inhibitors, 34 antihypertensive agents, 35 dehydrogenase inhibitors, 36 and insulin, 37 may be expected to modify VMA excretion, but only iproniazid 34 has thus far been reported to diminish VMA excretion to a significant degree.
Discussion
Tables 2 and 3 review the findings of other investigators who have assayed VMA excre-tion. 38 -* 7 Those using similar methods are in good agreement, whereas the eleetrophoretic 43 ' 44 and column chromatographic 43 procedures yield higher values. None of the tests offers greater reliability or equals the simplicity of the colorimetric techniques used in this study.
Although all of the methods appear to separate the VMA excretion of normal subjects from that of patients with pheochromoeytomas, Bollman et al. 42 studied two patients with elevated VMA and normal catecholamine excretion in whom chromaffin tumors were apparently not found. Kraupp et al. 38 described a patient with a pheochromoeytoma who excreted abnormally large quantities of VMA and catecholamines in the presence of paroxysmal hypertension but only large amounts of VMA between paroxysms. The intravenous administration of labeled epinephrine or norepinephrine is followed by brief excretion of the unmodified catechol but prolonged excretion of labeled VMA. 28 > 48> 49 The normal catecholamine excretion and elevated VMA excretion in a few of our patients with pheochromoeytomas may be explained on this basis.
As in the present study, Eobinson, Ratcliffe, and Smith 33 found no significant difference in VMA excretion between normal subjects and those with primary hypertension, von Studnitz 50 demonstrated slightly increased VMA excretion associated with the carcinoid syndrome. The same investigator also found that the monoamine oxidase inhibitor, iproniazid, interfered with, the formation of VMA. 34 Increased VMA excretion has been described in children with ganglioneuromas or neuroblastomas. 51 ' 52 Despite the apparent reliability of the VMA determination for the detection of pheochromoeytomas, alternative methods for the diagnosis of this tumor are both desirable and, at times, essential. Nevertheless, neither pharmacological testing nor the catecholamine determination fulfills all of the requirements for a practical screening procedure. Even Hingerty's recent catecholamine screening test, 42 
Summary
Methods for the determination of urinary vanillylmandelic acid (VMA) have been reviewed and variations in VMA excretion in different disease states summarized. The determination of VMA excretion is believed to represent a reliable method for the detection of a pheochromocytoma. Colorimetric screening tests for the detection of elevated VMA excretion have been reviewed and evaluated as laboratory aids in the diagnosis of pheochromocytoma. 21 
